BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, May 22, 2026
See today's BioWorld
Home
» Lilly’s oral GLP-1 milestone highlights a steady April for FDA approvals
To read the full story,
subscribe
or
sign in
.
Biopharma approvals April 2026
Lilly’s oral GLP-1 milestone highlights a steady April for FDA approvals
May 22, 2026
By
Amanda Lanier
No Comments
The U.S. FDA granted 14 approvals in April 2026, down from March’s 19 but broadly in line with the historical range for the month.
BioWorld
Analysis and data insight
Regulatory
FDA
